Segment Reporting Disclosure [Text Block] | 13. The Company's reportable segments consist of three not no The Company evaluates the performance of its segments based upon net operating income ("NOI"), which is a non-GAAP supplemental financial measure. The Company defines NOI for its segments as operating revenues (rental income, tenant reimbursements and other operating income) less property and related expenses (property operating expenses, real estate taxes, insurance, asset management fees, impairments and provision for bad debt) excluding interest expense. NOI excludes certain items that are not The following tables compare the Company's segment activity to its results of operations and financial position as of and for the three six June 30, 2024 June 30, 2023 Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Office/Industrial Properties: Rental, fees and other income $ 2,955,272 $ 3,020,066 $ 5,922,992 $ 5,882,064 Property and related expenses (1,294,149 ) (1,202,243 ) (2,676,542 ) (2,662,932 ) Net operating income, as defined 1,661,123 1,817,823 3,246,450 3,219,132 Model Home Properties: Rental, fees and other income 1,155,416 1,022,041 2,424,369 1,877,161 Property and related expenses (142,951 ) (46,801 ) (279,728 ) (77,797 ) Net operating income, as defined 1,012,465 975,240 2,144,641 1,799,364 Retail Properties: Rental, fees and other income 475,853 480,001 1,029,241 938,868 Property and related expenses (156,640 ) (128,351 ) (296,594 ) (266,149 ) Net operating income, as defined 319,213 351,650 732,647 672,719 Reconciliation to net income: Total net operating income, as defined, for reportable segments 2,992,801 3,144,713 6,123,738 5,691,215 General and administrative expenses (2,202,916 ) (1,813,184 ) (4,287,366 ) (3,777,804 ) Depreciation and amortization (1,351,370 ) (1,368,829 ) (2,702,388 ) (2,702,403 ) Interest expense (1,525,845 ) (1,336,415 ) (3,041,051 ) (2,204,182 ) Loss on Conduit Pharmaceuticals marketable securities (10,027,433 ) — (13,888,667 ) — Other income, net 5,206 398,085 9,852 1,140,201 Income tax expense (81,021 ) (349,074 ) (160,586 ) (497,527 ) Gain on sale of real estate 811,903 1,119,952 2,829,998 1,537,289 Net loss $ (11,378,675 ) $ (204,752 ) $ (15,116,470 ) $ (813,211 ) June 30, December 31, Assets by Reportable Segment: 2024 2023 Office/Industrial Properties: Land, buildings and improvements, net (1) $ 76,768,551 $ 77,472,724 Total assets (2) $ 77,076,636 $ 78,140,372 Model Home Properties: Land, buildings and improvements, net (1) $ 38,253,777 $ 50,790,147 Total assets (2) $ 39,538,041 $ 51,456,292 Retail Properties: Land, buildings and improvements, net (1) $ 15,863,447 $ 15,877,190 Total assets (2) $ 16,541,354 $ 16,539,399 Reconciliation to Total Assets: Total assets for reportable segments $ 133,156,031 $ 146,136,063 Other unallocated assets: Cash, cash equivalents and restricted cash 2,469,278 277,143 Other assets, net 14,912,974 29,549,432 Total Assets $ 150,538,283 $ 175,962,638 ( 1 Includes lease intangibles and the land purchase option related to property acquisitions. ( 2 Includes land, buildings and improvements, cash, cash equivalents, and restricted cash, current receivables, deferred rent receivables and deferred leasing costs and other related intangible assets, all shown on a net basis. For the Six Months Ended June 30, Capital Expenditures by Reportable Segment 2024 2023 Office/Industrial Properties: Capital expenditures and tenant improvements, office $ 1,010,815 $ 905,132 Model Home Properties: Acquisition of operating properties, model home 5,740,918 12,932,128 Retail Properties: Capital expenditures and tenant improvements, retail 203,121 96,704 Totals: Acquisition of operating properties, net 5,740,918 12,932,128 Capital expenditures and tenant improvements 1,213,936 1,001,836 Total real estate investments $ 6,954,854 $ 13,933,964 |